TY - JOUR
T1 - Faricimab Treat-and-Extend for Diabetic Macular Edema
T2 - Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials
AU - YOSEMITE and RHINE Investigators
AU - Wong, Tien Y.
AU - Haskova, Zdenka
AU - Asik, Kemal
AU - Baumal, Caroline R.
AU - Csaky, Karl G.
AU - Eter, Nicole
AU - Ives, Jane A.
AU - Jaffe, Glenn J.
AU - Korobelnik, Jean François
AU - Lin, Hugh
AU - Murata, Toshinori
AU - Ruamviboonsuk, Paisan
AU - Schlottmann, Patricio G.
AU - Seres, András I.
AU - Silverman, David
AU - Sun, Xiaodong
AU - Tang, Yannan
AU - Wells, John A.
AU - Yoon, Young Hee
AU - Wykoff, Charles C.
AU - Aaberg, Thomas
AU - Abbey, Ashkan
AU - Abdulaeva, Elmira
AU - Abengoechea, Santiago
AU - Abraham, Prema
AU - Ach, Thomas
AU - Adams, Serrhel
AU - Adan Civera, Alfredo
AU - Adrean, Sean
AU - Agostini, Hansjurgen
AU - Alam, Suhail
AU - Alezzandrini, Arturo
AU - Alfaro, Virgil
AU - Aliseda, Daniel
AU - Almony, Arghavan
AU - Amat, Pedro
AU - Amini, Payam
AU - Antoszyk, Andrew
AU - Arias, Luis
AU - Asaria, Riaz
AU - Avila, Marcos
AU - Awh, Carl C.
AU - Bafalluy, Joaquin
AU - Baker, Carl
AU - Bandello, Francesco
AU - Barakat, Mark
AU - Barraza, Karen
AU - Bator, Gyorgy
AU - Baumal, Caroline
AU - Chan, Clement
N1 - Copyright © 2024 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
PY - 2024/6
Y1 - 2024/6
KW - Angiopoietin-2
KW - Diabetic macular edema
KW - Faricimab
KW - Vascular endothelial growth factor A
KW - Vascular stability
KW - Intravitreal Injections
KW - Double-Blind Method
KW - Follow-Up Studies
KW - Tomography, Optical Coherence
KW - Humans
KW - Middle Aged
KW - Male
KW - Treatment Outcome
KW - Visual Acuity/physiology
KW - Recombinant Fusion Proteins/administration & dosage
KW - Macular Edema/drug therapy
KW - Antibodies, Monoclonal, Humanized/administration & dosage
KW - Female
KW - Angiogenesis Inhibitors/administration & dosage
KW - Angiopoietin-2/antagonists & inhibitors
KW - Aged
KW - Receptors, Vascular Endothelial Growth Factor/administration & dosage
KW - Vascular Endothelial Growth Factor A/antagonists & inhibitors
KW - Diabetic Retinopathy/drug therapy
UR - https://www.scopus.com/pages/publications/85187381197
UR - https://www.scopus.com/pages/publications/85187381197#tab=citedBy
UR - https://www.mendeley.com/catalogue/67a12fdc-163f-3d7a-ac86-0e935147aaa0/
U2 - 10.1016/j.ophtha.2023.12.026
DO - 10.1016/j.ophtha.2023.12.026
M3 - Article
C2 - 38158159
AN - SCOPUS:85187381197
SN - 0161-6420
VL - 131
SP - 708
EP - 723
JO - Ophthalmology
JF - Ophthalmology
IS - 6
ER -